Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02AVL
|
||||
| Drug Name |
ZK-813039
|
||||
| Synonyms |
DE-00684; Factor Xa inhibitor (oral), Schering AG/Pfizer; ZK-813039
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Unspecified | Investigative | [528872] | ||
| Formula |
C23H19Cl3N6O3S
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Coagulation factor Xa | Target Info | Modulator | [528872] | |
| KEGG Pathway | Complement and coagulation cascades | ||||
| PANTHER Pathway | Blood coagulation | ||||
| Pathway Interaction Database | Beta2 integrin cell surface interactions | ||||
| PathWhiz Pathway | Coagulation | ||||
| Reactome | Extrinsic Pathway of Fibrin Clot Formation | ||||
| Intrinsic Pathway of Fibrin Clot Formation | |||||
| Common Pathway of Fibrin Clot Formation | |||||
| Gamma-carboxylation of protein precursors | |||||
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.